NYSE Euronext — Q1 2013 Earnings Presentation
22 slides from NYSE Euronext's earnings presentation, Apr 30, 2013
Slide 1: NYSE Euronext First Quarter 2013 Earnings Presentation
NYSE EURONEXT FIRST QUARTER 2013 EARNINGS PRESENTATION April 30, 2013
Slide 2: Legal Disclaimers
LEGAL DISCLAIMERS Non-GAAP Financial Measures To supplement NYSE Euronext’s consolidated financial statements prepared in accordance with GAAP and to better reflect period-over-period comparisons, NYSE Euronext uses non-GAAP financial measures of performance, financial position, or cash flows that e
Slide 3: Legal Disclaimers
LEGAL DISCLAIMERS IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE TO FIND IT This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction, ICE has fi
Slide 4: 1Q13 Highlights
1Q13 HIGHLIGHTS Diluted EPS 2 of $0.57, up 21% vs. 1Q12; Up 33% vs. 4Q12 $600 million in net revenues 3, in-line with 1Q12; Up 7% from 4Q12 Other operating expenses 4 of $380 million, down 8% on constant dollar / Our Results 1 portfolio basis Operating income 4 of $220 million, up 12% vs. 1Q
Slide 5: We Are Executing Against Our Plans
WE ARE EXECUTING AGAINST OUR PLANS Unlocking the Power of the Community Access to GROWTH Operating Leverage and Flexibility for Opportunities EFFICIENCY Strategic CAPITAL Deployment IN PROGRESS IN PROGRESS IN PROGRESS Clearing Clearing Review of investment portfolio- Launch new derivatives p
Slide 6: FICC Update
FICC UPDATE LIFFE EU ADV (Contracts) FICC Products ADV ADV (Contracts) Gilt Futures ADV and OI OI (Contracts) 3,000,000 Euribor Futures Euribor Options Sterling Futures 200,000 Gilt Futures OI 450,000 180,000 400,000 Sterling Options Commodities 2,500,000 160,000 350,000 140,000 300,000 2,000,000 12
Slide 7: Equity Derivatives Update
EQUITY DERIVATIVES UPDATE U.S. Equity Options FTSE Equity Derivatives ADV (Contracts) U.S. Equiyt Options ADV & Market Share Combined M/S Total Contract Vol. FTSE Franchise Volume OI (Contracts) 6,000,000 30.0% 20,000,000 5,000,000 18,000,000 5,000,000 25.0% 16,000,000 4,000,000 4,000,000 20.0% 14,0
Slide 8: Cash Equities Update
CASH EQUITIES UPDATE ($ in millions) European Cash U.S. Cash ADV Trades in thousands ADV Shares in millions ADV & Net Trading Revenue Generation ADV & Net Trading Revenue Generation $59 $47 $53 1,783 $38 $40 1,583 $44 1,378 1,179 1,551 1,545 1Q12 4Q12 1Q13 1Q12 4Q12 1Q13 Source: NYSE Euronext Source
Slide 9: Strong Momentum in Listings
STRONG MOMENTUM IN LISTINGS #1 in global IPO and follow-on proceeds – over 4X more IPO proceeds and nearly 3X more follow-on proceeds than nearest competitor 75% U.S. technology IPO market share – three new NYSE technology IPOs in Q1 2013, Marin Software, Model N, and Silver Spring Networks Q1 2
Slide 10: NYSE Technologies
NYSE TECHNOLOGIES Market Solutions Transactions Colocation FIX Enterprise Services Software Liquidity DART Solutions SFTI Partner Management Connectivity Products FIX Services Middleware Software Content Infrastructure SFTI Cloud Services Consolidated Solutions Solutions Feed Services SFTI Managed S
Slide 11: ICE / NYX Pro Forma
ICE / NYX PRO FORMA Combined business well diversified across asset classes, products and geographies Pro Forma Business Mix: Net Revenues Pro Forma Product Mix: Futures Volumes 3 CDS Other Cash Trading 4% 8% 10% Index Futures & 10% Options 1 Energy & Listings 4 44% Emissions 12% LTM Net LTM 51% Rev
Slide 12: ICE / NYX Transaction Timeline
ICE / NYX TRANSACTION TIMELINE Competition Review 3/18/13 2/15/13 Filed for US 4/23/13 referral by May / June competition EC confirmed UK, Spain & 2013 1/16/13 clearance to oversee • Phase 1 25 days Portugal to Anticipate Filed with US under the the European HSR Act European submission of • Phase 2
Slide 13: GAAP 1Q13 Financial Results
GAAP 1Q13 FINANCIAL RESULTS ($ in millions, except per share data) 1Q13 4Q12 1Q12 Total Revenue¹ $963 $909 $952 Operating Income $202 $97 $165 Net Income $126 $28 $87 Diluted EPS $0.52 $0.12 $0.34 Pre-tax Adjustments 1Q13 4Q12 1Q12 Merger & Other Exit Costs ($8) ($24) ($31) Charge for RSU Fair Value
Slide 14: Non-GAAP 1Q13 Financial Results
NON-GAAP 1Q13 FINANCIAL RESULTS ($ in millions, except per share data) % ∆ 1Q13 1Q13 4Q12 1Q12 vs. 1Q12 Total Revenue¹ $963 $909 $952 1% Transaction-based Expenses² $363 $347 $351 3% Total Revenues, Less Transaction-based Expenses $600 $562 $601 − Other Operating Expenses 3 $380 $389 $405 (6%) Opera
Slide 15: Derivatives Highlights
DERIVATIVES HIGHLIGHTS ($ in millions) % ∆ 1Q13 1Q13 4Q12 1Q12 vs. 1Q12 Total Revenue $293 $221 $229 28% Net Revenue¹ $201 $160 $176 14% % of total 34% 28% 29% Other Operating Expenses² $97 $97 $97 − Operating Income² $104 $63 $79 32% % of total 3 43% 32% 35% Operating Margin ² 52% 39% 45% 7 ppts EB
Slide 16: Derivatives Trading Volumes and Capture
DERIVATIVES TRADING VOLUMES AND CAPTURE ($ in millions) European Derivatives ADV Contracts in thousands 1Q12 2Q12 3Q12 4Q12 1Q13 6,000 4,654 Total Revenue $ 147 $ 161 $ 143 $ 133 $ 195 4,515 4,000 3,332 3,383 3,534 883 Liquidity Payments (33) (37) (34) (32) (55) 1,743 673 829 1,190 Routing and Clear
Slide 17: Cash Trading & Listings Highlights
CASH TRADING & LISTINGS HIGHLIGHTS ($ in millions) % ∆ 1Q13 1Q13 4Q12 1Q12 vs. 1Q12 Total Revenue¹ $558 $568 $602 (7%) Net Revenue² $287 $282 $304 (6%) % of total 48% 50% 51% Other Operating Expenses3 $173 $182 $185 (6%) Operating Income3 $114 $100 $119 (4%) % of total 4 47% 51% 53% Operating Margin
Slide 18: Cash Trading Volumes and Capture
CASH TRADING VOLUMES AND CAPTURE ($ in millions) European Cash ADV Trades in thousands 1Q12 2Q12 3Q12 4Q12 1Q13 2,000 1,709 Total Revenue $ 59 $ 55 $ 46 $ 44 $ 53 1,583 1,318 1,378 1,500 1,179 Liquidity Payments - - - - - 1,000 Routing and Clearing - - - - - Net Revenue $ 59 $ 55 $ 46 $ 44 $ 53 500
Slide 19: Info. Svcs. & Tech. Solutions Highlights
INFO. SVCS. & TECH. SOLUTIONS HIGHLIGHTS ($ in millions) % ∆ 1Q13 1Q13 4Q12 1Q12 vs. 1Q12 Total Revenue $112 $120 $121 (7%) % of total 19% 21% 20% Other Operating Expenses1 $87 $85 $93 (6%) Operating Income1 $25 $35 $28 (11%) % of total 2 10% 18% 12% Operating Margin 1 22% 29% 23% (1 ppt) EBITDA Mar
Slide 20: P14 Operating Expense Reconciliation & FY 2013 Guidance
P14 OPERATING EXPENSE RECONCILIATION & FY 2013 GUIDANCE ($ in millions) Project 14 Base Trailing FY Guidance Other Operating Expenses¹ 2011 12 Months 2013 Non-GAAP Expenses ($1,666) ($1,553) ($1,525) P14 Currency Rates Adjustment2 - ($15) ($15) Non-GAAP Expenses Rebased ($1,666) ($1,568) ($1,540) Im
Slide 21: Strong Balance Sheet & Liquidity
STRONG BALANCE SHEET & LIQUIDITY ($ in billions) Cash & Investment Securities $0.5 Total Debt $2.5 ► 2.0% $850m notes due Oct 2017 $0.9 Key ► 5.375% €1bn notes due June 2015 $1.2 ► 4.8% $750m notes due June 2013 $0.4 Balance Sheet ► Commercial paper in $ and € $0.0 Indicators as of Net Debt $2.0 3/3
Slide 22: Slide 22